Retatrutide is a triple hormone receptor agonist. It works by affecting three receptors: GLP-1, GIP, and glucagon. In comparison, tirzepatide targets only...
For decades, metabolic pharmacology focused on one goal: reducing calorie intake. GLP-1 compounds first proved this idea. Dual agonists refined it further....
Introduction Retatrutide is a triple-receptor agonist; it activates GLP-1, GIP, and glucagon receptors simultaneously. It comes as a freeze-dried powder inside a...
Quick Answer: What Is Retatrutide?Retatrutide (LY3437943) is an investigational once-weekly injection made by Eli Lilly. It is a novel therapy that simultaneously...